Systemic inhibition of bone morphogenetic protein 1.3 as a possible treatment for laminin-related congenital muscular dystrophy.
Saved in:
| Title: | Systemic inhibition of bone morphogenetic protein 1.3 as a possible treatment for laminin-related congenital muscular dystrophy. |
|---|---|
| Authors: | Matic Jelic I; Laboratory for Mineralized Tissues, University of Zagreb School of Medicine, Zagreb, Croatia., Stokovic N; Laboratory for Mineralized Tissues, University of Zagreb School of Medicine, Zagreb, Croatia., Ivanjko N; Laboratory for Mineralized Tissues, University of Zagreb School of Medicine, Zagreb, Croatia., Pecina M; Department of Orthopaedic Surgery, University of Zagreb School of Medicine, Zagreb, Croatia., Kufner V; Laboratory for Mineralized Tissues, University of Zagreb School of Medicine, Zagreb, Croatia., Bordukalo Niksic T; Laboratory for Mineralized Tissues, University of Zagreb School of Medicine, Zagreb, Croatia., Vukicevic S; Laboratory for Mineralized Tissues, University of Zagreb School of Medicine, Zagreb, Croatia. slobodan.vukicevic@mef.hr. |
| Source: | International orthopaedics [Int Orthop] 2025 Jan; Vol. 49 (1), pp. 45-52. Date of Electronic Publication: 2024 Dec 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7705431 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5195 (Electronic) Linking ISSN: 03412695 NLM ISO Abbreviation: Int Orthop Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
